Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navid Shomali

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Cell Communication and Signaling : CCS|June 2, 2022
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)Rebar N Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
European Journal of Pharmacology|December 13, 2021
Potential anti-inflammatory effect of anti-HMGB1 in animal models of ICH by downregulating the TLR4 signaling pathway and regulating the inflammatory cytokines along with increasing HO1 and NRF2Ji Xu, Sahar Mashayekhi Firouz, Mina Farrokhian, et al.
Stem Cell Research & Therapy|March 30, 2021
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimismFaroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling : CCS|April 8, 2022
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and consAdel Naimi, Rebar N Mohammed, Ahmed Raji, et al.
Biotechnology and Applied Biochemistry|March 31, 2021
Under hypoxic conditions, MSCs affect the expression and methylation level of survival-related genes in ALL independent of apoptosis pathways in vitroFaroogh Marofi, Navid Shomali, Laith A Younus, et al.
Stem Cell Research & Therapy|March 23, 2021
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapyFaroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Thangavelu, et al.
Gene|August 22, 2022
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitisNavid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, et al.
Genes & Diseases|June 10, 2022
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancersMehdi Sajjadi-Dokht, Talar Ahmad Merza Mohamad, Heshu Sulaiman Rahman, et al.
Stem Cell Research & Therapy|January 26, 2021
CAR T cells in solid tumors: challenges and opportunitiesFaroogh Marofi, Roza Motavalli, Vladimir A Safonov, et al.
IUBMB Life|June 12, 2021
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 virusesRoza Motavalli, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Cell Communication and Signaling : CCS|June 2, 2022
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)Rebar N Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
European Journal of Pharmacology|December 13, 2021
Potential anti-inflammatory effect of anti-HMGB1 in animal models of ICH by downregulating the TLR4 signaling pathway and regulating the inflammatory cytokines along with increasing HO1 and NRF2Ji Xu, Sahar Mashayekhi Firouz, Mina Farrokhian, et al.
Stem Cell Research & Therapy|March 30, 2021
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimismFaroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling : CCS|April 8, 2022
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and consAdel Naimi, Rebar N Mohammed, Ahmed Raji, et al.
Biotechnology and Applied Biochemistry|March 31, 2021
Under hypoxic conditions, MSCs affect the expression and methylation level of survival-related genes in ALL independent of apoptosis pathways in vitroFaroogh Marofi, Navid Shomali, Laith A Younus, et al.
Stem Cell Research & Therapy|March 23, 2021
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapyFaroogh Marofi, Heshu Sulaiman Rahman, Lakshmi Thangavelu, et al.
Gene|August 22, 2022
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitisNavid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, et al.
Genes & Diseases|June 10, 2022
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancersMehdi Sajjadi-Dokht, Talar Ahmad Merza Mohamad, Heshu Sulaiman Rahman, et al.
Stem Cell Research & Therapy|January 26, 2021
CAR T cells in solid tumors: challenges and opportunitiesFaroogh Marofi, Roza Motavalli, Vladimir A Safonov, et al.
IUBMB Life|June 12, 2021
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 virusesRoza Motavalli, Walid Kamal Abdelbasset, Heshu Sulaiman Rahman, et al.
Pageof 8